Impact of T Lymphocytes Isolated from Liver Perfusate of Deceased Brain Donors on Kidney Transplantation: Preliminary Evidence and Future Directions

Background: Ischemia/reperfusion injury (IRI), acute rejection (AR), and delayed graft function (DGF) might occur as major complications following kidney transplantation. Thus, the identification of biomarkers for the IRI, AR, and/or DGF development becomes crucial as it may help to guide post-transplant management. Natural killer (NK) cells, hepatic interstitial T-lymphocytes (T-Li), and NK-T cells are crucial in both innate and adaptive immunity after abdominal solid organ transplantation. Hence, the aim of this study was to evaluate the impact of the immune system after graft reperfusion during KT in adults in order to identify predictive biomarkers. Methods: The NK, T-Li, and NK-T phenotypes and concentrations were retrospectively analyzed in a consecutive series of liver perfusates obtained after organ procurement flushing the abdominal cavity recovered from deceased brain donors (DBDs). Their percentage was compared with the renal transplant recipients’ characteristics with kidneys taken from the same DCDs. The hepatic perfusate cells were purified by density gradient centrifugation. Flow cytometric investigation was used to determine their phenotype with the following immunological markers in order to determine the relative percentage of T-Li, NK-T, and NK cells: CD3, CD4, CD8, and CD56. Results: 42 DBDs’ liver perfusates were analyzed. The related clinical outcomes of kidney transplant recipients from 2010 to 2020 performed at our Institute were evaluated. Time in days of delayed functional recovery of transplanted kidneys (DGF) (p = 0.02) and the onset of secondary infection from a cytomegalovirus (p = 0.03) were significantly associated with the T-Li percentage. An increased relative risk (HR) of organ survival was significantly associated with the percent cell concentration of T-Li and time to DGF, on COX analysis, were (HR = 1.038, p = 0.04; and HR = 1.029, p = 0.01, respectively). None relevant clinical outcomes in kidney transplant patients were associated with the specificity of the NK and NK-T cell proportions. Conclusions: A new potential role of T-Li cells was detected in the context of hepatic perfusate from DBDs. It could detect potential impacts in organ allocation, surgical procuring techniques, and in the analysis of IRI pathophysiological events.

[1]  E. Rhee Kidney-specific metabolomic profiling in machine perfusate. , 2023, Kidney international.

[2]  H. Cardinal,et al.  Hypothermic Perfusion Modifies the Association Between Anti-LG3 Antibodies and Delayed Graft Function in Kidney Recipients , 2023, Transplant International.

[3]  C. Niemann,et al.  Hypothermia or Machine Perfusion in Kidney Donors. , 2023, The New England journal of medicine.

[4]  M. Bellini,et al.  Organ Reconditioning and Machine Perfusion in Transplantation , 2023, Transplant International.

[5]  Z. Moon,et al.  Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial , 2023, EClinicalMedicine.

[6]  Martijn P. D. Haring,et al.  A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. , 2023, Journal of hepatology.

[7]  P. Reese,et al.  Untargeted metabolomics of perfusate and their Association with pump perfusion and allograft failure. , 2022, Kidney international.

[8]  S. Parajuli,et al.  Delayed graft function: current status and future directions , 2022 .

[9]  A. Mehrabi,et al.  Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial , 2022, BMJ Open.

[10]  U. Sack,et al.  The Role of Innate Immune Cells in the Prediction of Early Renal Allograft Injury Following Kidney Transplantation , 2022, Journal of clinical medicine.

[11]  Maria Rita Gulotta,et al.  Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection , 2022, Viruses.

[12]  K. Asehnoune,et al.  Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME) , 2022, BMJ Open.

[13]  I. Mucsi,et al.  Normothermic Ex Vivo Kidney Perfusion for Human Kidney Transplantation: First North American Results , 2022, Transplantation.

[14]  A. Gallo,et al.  Human Amnion-Derived Mesenchymal Stromal/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia/Reperfusion , 2022, Cells.

[15]  A. Rajab,et al.  Machine perfusion of kidney allografts affects early but not late graft function. , 2021, American journal of surgery.

[16]  S. Serni,et al.  Delayed graft function and perfusion parameters of kidneys from uncontrolled donors after circulatory death , 2020, Perfusion.

[17]  J. Hoheisel,et al.  Phase-I trial of donor-derived modified immune cell infusion in kidney transplantation. , 2020, The Journal of clinical investigation.

[18]  R. Liotta,et al.  Crucial Role of Extended Criteria Donors in Deceased Donor Single Kidney Transplantation to Face Chronic Shortage in the Heart of the Mediterranean Basin: A Single-Center Experience. , 2019, Transplantation proceedings.

[19]  F. Claas,et al.  Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies , 2019, Scientific Reports.

[20]  R. Liotta,et al.  Liver Perfusate Natural Killer Cells From Deceased Brain Donors and Association With Acute Cellular Rejection After Liver Transplantation: A Time-to-Rejection Analysis , 2019, Transplantation.

[21]  David W. Johnson,et al.  Association Between Duration of Delayed Graft Function, Acute Rejection, and Allograft Outcome After Deceased Donor Kidney Transplantation , 2019, Transplantation.

[22]  D. Bumann,et al.  Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti‐Pathogen Immunity , 2019, Immunity.

[23]  Alessandro Nanni Costa,et al.  A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  R. Lechler,et al.  T-cell alloimmunity and chronic allograft dysfunction. , 2010, Kidney international. Supplement.

[25]  G. Pietrosi,et al.  Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. , 2009, World journal of gastroenterology.

[26]  G. Pietrosi,et al.  Clinical applications of hepatocyte transplantation. , 2009, World journal of gastroenterology.

[27]  E. Engleman,et al.  Tolerance and chimerism after renal and hematopoietic-cell transplantation. , 2008, The New England journal of medicine.

[28]  W. Weimar,et al.  Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. , 2000, Transplantation.

[29]  N. Perico,et al.  Peripheral donor leukocytes prolong survival of rat renal allografts. , 1999, Kidney international.

[30]  B. Griffith,et al.  Infusion of donor leukocytes to induce tolerance in organ allograft recipients , 1999, Journal of leukocyte biology.